loader
Please Wait
Applying Filters...
menu
    • menu

    Setid D8a94e6e 2f61 4589 Bb73 65c9c7884797 Applno 20613 Form Solution Drops Ophthalmic Dosage 0 2 - Drug Product Composition: 59803-98-4 (Parent)

    Menu

    59803-98-4 (Parent)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20613 / DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    brimonidine tartrate(UNII: 4S9CL2DY2H)
    (brimonidine - UNII:E6GNX3HHTE)     		brimonidine tartrate2mg in 1

    Inactive Ingredients

    Ingredient Name
    Pacific Pharma, Inc.
    benzalkonium chloride(F5UM2KM3W7)
    citric acid monohydrate(2968PHW8QP)
    hydrochloric acid(QTT17582CB)
    polyvinyl alcohol(532B59J990)
    sodium chloride(451W47IQ8X)
    sodium citrate(1Q73Q2JULR)
    sodium hydroxide(55X04QC32I)
    water(059QF0KO0R)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.